Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

ConforMIS

12 Disclosed Funding Rounds $523,299,000

0 Participating Investments


Therapeutics, Medical Device, Health Care

ConforMIS develops personalized, patient-specific implants and instrumentation for knee-related therapeutics.

Burlington, Massachusetts, United States, North America (US)

Organizations in Burlington in Therapeutics,
Organizations in Burlington in Medical Device,
Organizations in Burlington in Health Care,
Organizations in Massachusetts in Therapeutics,
Organizations in Massachusetts in Medical Device,
Organizations in Massachusetts in Health Care,
Organizations in United States in Therapeutics,
Organizations in United States in Medical Device,
Organizations in United States in Health Care,
Organizations in North America in Therapeutics,
Organizations in North America in Medical Device,
Organizations in North America in Health Care

Investors in Burlington in Therapeutics,
Investors in Burlington in Medical Device,
Investors in Burlington in Health Care,
Investors in Massachusetts in Therapeutics,
Investors in Massachusetts in Medical Device,
Investors in Massachusetts in Health Care,
Investors in United States in Therapeutics,
Investors in United States in Medical Device,
Investors in United States in Health Care,
Investors in North America in Therapeutics,
Investors in North America in Medical Device,
Investors in North America in Health Care

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 2004

Founders Philipp Lang, Daniel Steines

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which it refers to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.

Date Round Raised Lead
February, 12, 2021 Post-IPO Equity $85,000,000 -------
June, 26, 2019 Post-IPO Debt $30,000,000 East West Bank, Innovatus Capital Partners
June, 26, 2019 Post-IPO Equity $3,000,000 -------
January, 09, 2017 Debt Financing $50,000,000 Oxford Finance LLC
August, 02, 2013 Series E $167,700,000 -------
January, 30, 2012 Series E $89,000,000 AGC Equity Partners, Axel Johnson
July, 12, 2011 Debt Financing $1,400,000 -------
August, 10, 2009 Series D $50,000,000 Aeris Capital
July, 09, 2008 Series D $14,915,000 -------
August, 06, 2007 Debt Financing $10,000,000 -------
November, 06, 2006 Series C $12,092,000 -------
October, 12, 2004 Series B $10,192,000 -------

ConforMIS Investors (21)

Investor Lead? Round Participating Raise Date Partners
East West Bank Yes Post-IPO Debt $30,000,000 June, 26, 2019 -------
Innovatus Capital Partners Yes Post-IPO Debt $30,000,000 June, 26, 2019 -------
Oxford Finance LLC Yes Debt Financing $50,000,000 January, 09, 2017 -------
SWFI No Series E $167,700,000 August, 02, 2013 -------
Eaton Gate Capital Partners No Series E $167,700,000 August, 02, 2013 -------
Axel Johnson No Series E $167,700,000 August, 02, 2013 -------
AGC Equity Partners No Series E $167,700,000 August, 02, 2013 -------
AGC Equity Partners Yes Series E $89,000,000 January, 30, 2012 -------
Axel Johnson Yes Series E $89,000,000 January, 30, 2012 -------
Aeris Capital Yes Series D $50,000,000 August, 10, 2009 -------
Thorner Ventures No Series D $14,915,000 July, 09, 2008 -------
Aeris Capital No Series D $14,915,000 July, 09, 2008 -------
Veron International No Series D $14,915,000 July, 09, 2008 -------
CDIB BioScience Ventures No Series D $14,915,000 July, 09, 2008 -------
Boston Life Science Venture No Series D $14,915,000 July, 09, 2008 -------
Merrill Lynch No Debt Financing $10,000,000 August, 06, 2007 -------
Veron International No Series C $12,092,000 November, 06, 2006 -------
Thorner Ventures No Series C $12,092,000 November, 06, 2006 -------
Industrial Bank of Taiwan No Series C $12,092,000 November, 06, 2006 -------
Veron International No Series B $10,192,000 October, 12, 2004 -------
Thorner Ventures No Series B $10,192,000 October, 12, 2004 -------